BioSpace News Archive

XBiotech Inc. (NASDAQ: XBIT) announced today it has achieved a crucial milestone in the development of its next generation inflammation-fighting True Human antibodies.

New Data Suggests Nutraceutical Product May Amplify Known Beneficial Effects of AMPK Activation in Pulmonary Inflammation

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, is pleased to report that the European Medicines Agency (EMA) has accepted its Pediatric Investigation Plan (PIP)

71% of Consumers are Afraid That Restrictions in Their Communities are Being Lifted too Quickly; 82% Say the World now Seems Like a Riskier Place

eRx designed with “Clinical Decision Support” to make prescribing safer for patients and more efficient for providers

- Pulmonology opinion leaders in ARDS therapies will bring invaluable insight in Company’s clinical trial design

X-Nav Technologies, LLC announced that it has received 510(k) Clearance from the U.S. Food & Drug Administration for X-Mark™, a new virtual patient registration technology that advances navigated dental implant surgery

Only 39 Percent of Commercial Leaders Report a Strong to Very Strong Relationship with Medical Affairs Team, According to a New TGaS Landscape Report from Trinity Life Sciences

Exploratory Phase 1b/2 trial targeting a heterogeneous population of patients with HPV16-positive, recurrent and/or metastatic cancer whose disease has progressed after up to three lines of chemotherapy, reports promising clinical activity with the combination regimen. Patient follow-up and translational analyses are ongoing. Full results will be presented at an upcoming scientific conference. Transgene intends to continue the

LifeOmic, the creators of LIFE mobile apps, today announced the launch of premium versions of the LIFE Extend and LIFE Fasting Tracker apps